Inozyme Pharma Q3 EPS $(0.60) Up From $(1.55) YoY

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.60) per share. This is a 61.29 percent increase over losses of $(1.55) per share from the same period last year.

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.60) per share. This is a 61.29 percent increase over losses of $(1.55) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Earnings Preview: DHT Holdings

DHT Holdings (NYSE:DHT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that DHT Holdings will report an earnings per share (EPS) of $-0.01.

DHT